29 results
8-K
EX-99.1
APGE
Apogee Therapeutics Inc.
5 Mar 24
Regulation FD Disclosure
8:15am
warning to the class due to increased risk of CV events and death; patients must step through biologic to get to JAKi JAK inhibitor Phase 2 objectives … cause of death in the US in 2019 150K+ People die each year in the US No biologic therapies are approved for COPD, but DUPIXENT demonstrated promise
10-K
2023 FY
APGE
Apogee Therapeutics Inc.
5 Mar 24
Annual report
6:15am
population 40 years of age and older have COPD, and in 2019 (prior to the COVID–19 pandemic), COPD was the third leading cause of death globally … of death with no approved biologics. COPD affects more than 32 million adults 40 years of age and older in the United States, France, Germany, Italy
DRS
APGE
Apogee Therapeutics Inc.
9 Feb 24
Draft registration statement
12:00am
need in COPD, a leading cause of death with no approved biologics.
Potential for expansion into a broad range of I&I indications, including asthma … to the COVID-19 pandemic), COPD was the third leading cause of death globally. In the United States, over 150,000 people die of COPD each year.
Three
10-Q
2023 Q2
EX-3.1
APGE
Apogee Therapeutics Inc.
28 Aug 23
Quarterly report
8:00am
from death, resignation, retirement, disqualification, removal from office or other cause shall be filled
solely by the affirmative vote … , whichever occurs earlier, subject to his or her earlier death, disqualification, resignation or removal. Except as otherwise provided for or fixed
10-Q
2023 Q2
EX-10.9
APGE
Apogee Therapeutics Inc.
28 Aug 23
Quarterly report
8:00am
the Participant’s death by the Participant’s beneficiaries or as permitted by the Committee and (b) as permitted by the Committee, a Participant may … Participant’s death, by the Participant’s beneficiaries or as otherwise permitted by the Committee) and provided further that such Assignee Entity shall
10-Q
EX-3.2
bpdrdy
28 Aug 23
Quarterly report
8:00am
424B4
b2gi gp1ndr2
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1/A
EX-3.4
p8eggd76
3 Jul 23
IPO registration (amended)
4:44pm
S-1/A
EX-10.14
ulf40w37l 9ipeiggcg
3 Jul 23
IPO registration (amended)
4:44pm
S-1/A
EX-3.5
db13wlktocekx6mncvwx
3 Jul 23
IPO registration (amended)
4:44pm
S-1/A
EX-10.15
jg2uq 32vc
3 Jul 23
IPO registration (amended)
4:44pm
S-1
EX-10.11
nwaap957
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.3
1heajwz q0
22 Jun 23
IPO registration
4:19pm
S-1
EX-10.4
ws12igvy
22 Jun 23
IPO registration
4:19pm
S-1
EX-3.1
432qcpcdqqxrvb1wy1
22 Jun 23
IPO registration
4:19pm
S-1
42url4fu
22 Jun 23
IPO registration
4:19pm